GlassScriptPhysician profile
Eugene D Bell
NPI 1588992168
$5,293.45
in general payments reported to CMS, 2019-2025
38 companies · $1,098 in 2025
The $1,098 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $322 · 2022: $1,061 · 2023: $1,122 · 2024: $1,154 · 2025: $1,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,373.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $555.46 | 2019-2025 | Provenge |
| Merck Sharp & Dohme LLC | $443.63 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $437.85 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Astellas Pharma US INC | $408.42 | 2019-2024 | Xtandi, Myrbetriq |
| Pfizer INC. | $381.27 | 2019-2025 | |
| Procept Biorobotics Corporation | $367.02 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Abbvie INC. | $327.42 | 2019-2025 | Botox |
| Sumitomo Pharma America, INC. | $296.69 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $263.95 | 2020-2025 | |
| Olympus America INC. | $205.34 | 2023-2025 | Itind System |
| Boston Scientific Corporation | $198.71 | 2019-2020 | |
| Urogen Pharma, INC. | $136.62 | 2023-2024 | Jelmyto |
| Coloplast Corp | $124.43 | 2020-2025 | |
| Endo Pharmaceuticals INC. | $123.73 | 2022-2023 | Xiaflex, Aveed, Edex |
| Antares Pharma, INC. | $123.41 | 2019-2025 | Xyosted, Nocdurna, Tlando |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.